13F-HR filed by Sofinnova Investments, Inc.
Sofinnova Investments, Inc. filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-13, with 60 holding rows worth $1,259,985,107.
- Accession
- 0001104659-24-117589
- Filer
- CIK 1631134
- Filed
- 2024-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 62 entries on the cover page, a total value of $1,259,985,107 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,259,985,107 with VALUE read as dollars as filed, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NATERA INC COM | 632307104 | Stock | 1,550,280 | $196,808,046 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 2,793,987 | $123,494,225 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 726,329 | $86,483,994 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 809,406 | $63,060,821 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,749,455 | $55,422,734 | dollars as filed | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 3,518,684 | $51,689,468 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 2,304,901 | $47,941,941 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 714,176 | $47,207,034 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 1,995,594 | $40,869,765 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 1,696,752 | $39,873,672 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 379,527 | $34,108,091 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 586,344 | $29,604,509 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 2,194,278 | $28,854,756 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 772,070 | $27,732,754 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,265,230 | $24,464,484 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 5,662,550 | $24,009,212 | dollars as filed | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 200,000 | $23,004,000 | dollars as filed | put |
| INOZYME PHARMA INC | 45790W108 | COM | 4,280,308 | $22,386,011 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 188,562 | $21,007,692 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 286,307 | $20,900,411 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 786,999 | $15,149,731 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 300,000 | $15,147,000 | dollars as filed | put |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 276,678 | $14,495,160 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 150,000 | $13,480,500 | dollars as filed | put |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 202,898 | $13,389,239 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 135,819 | $11,381,632 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 600,302 | $11,117,593 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 384,767 | $10,269,431 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 676,766 | $9,894,319 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 406,645 | $9,328,436 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 203,271 | $9,218,340 | dollars as filed | |
| INHIBRX BIOSCIENCES INC | 45720N103 | COM | 536,068 | $8,394,825 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 358,644 | $8,388,683 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 3,758,686 | $7,855,654 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 181,476 | $7,852,467 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 4,386,177 | $7,719,672 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 164,770 | $7,485,501 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,533,883 | $7,239,928 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 1,514,032 | $7,176,512 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 296,884 | $5,801,113 | dollars as filed | |
| PHIBRO ANIMAL HEALTH CORP (CLA | 71742Q106 | CL A COM | 238,184 | $5,363,904 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 40,611 | $5,296,081 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,842,668 | $5,030,484 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 386,100 | $4,405,401 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 90,327 | $3,725,085 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 15,191 | $3,662,550 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 2,671,856 | $3,660,443 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 5,770 | $3,569,149 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 37,637 | $2,563,832 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 41,352 | $2,032,037 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 2,754,437 | $1,784,875 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 38,792 | $1,702,581 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 120,632 | $1,610,437 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 30,472 | $1,399,579 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 129,246 | $968,053 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 85,640 | $942,896 | dollars as filed | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 366,568 | $852,271 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 382,616 | $661,926 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 48,138 | $527,592 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 62,313 | $516,575 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-24-117589 | this filing | 2024-11-13 | acceptance time not in the bulk data set |